FTC Supports Federal DTC Ad Inquiry

Share this article:
The Federal Trade Commission is supporting efforts by the Food and Drug Administration to survey patients and doctors to determine the effects of direct-to-consumer pharmaceutical advertising.


FDA officials are trying to determine the potential benefits and harms caused by DTC ads. In comments submitted Thursday to the U.S. Office of Management and Budget, the FTC proposed additional inquiries into DTC effects on insurance and drug costs.


Such surveys could help officials evaluate whether DTC ads lead to lower prescription drug prices, the FTC said.


In June, the American Medical Association called for increased disclosures in DTC drug ads due to fears that the ads drive up drug prices by convincing consumers to request brand-name drugs when cheaper generics suffice.


Pharmaceutical Research and Manufacturers of America has stated that DTC drug ads empower consumers by helping them make their own healthcare choices.


Share this article:

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

AmEx Veteran Takes COO Role at Acxiom

AmEx Veteran Takes COO Role at Acxiom

Kerry Hatch ran American Express's OPEN business card division and led units at Starwood and Time Inc.

Red Roof Inn Turns Weather Woes Into Major Sales

Red Roof Inn Turns Weather Woes Into Major ...

The hotel chain woos stranded airline passengers with deals based on flight cancellations.

Signal Wants to Help CMOs Put Vendors to the Test

Signal Wants to Help CMOs Put Vendors to ...

The company claims its new Signal Tag can quintuple the number of A/B vendor tests marketers can do each year.